However, O-GlcNAcylation interferes with electron transport chain processes and enzymes involved in aerobic respiration, further interfering with substrate oxidation processes 33,48
When to speak to your GP or oncologist Contact your GP, prescriber, or oncology team if you experience: Any new lumps, changes in the affected or unaffected breast, or new symptoms that prompt concern about recurrence Persistent nausea or vomiting that stops you from keeping fluids down Rapid or significant weight loss beyond whats expected Signs of dehydration (dark urine, dizziness, reduced urination) New fatigue that feels different from your post-treatment fatigue Worsening joint pain or new bone pain Increasing anxiety, low mood, or fear of recurrence thats affecting daily life Any difficulty attending cancer follow-up appointments because of side effects Dont delay routine cancer surveillance because of Wegovy
Follow detailed plans to increase doses
Combine with formulary plan changes
In conclusion, ED is not merely a marker but a mechanistic driver of CVD
Involvement of Ser-451 and Ser-452 in the catalysis of human -glutamyl transpeptidase
